Screening for Aerosol-Generating Procedure Exposure Risk

Abstract

Exposure to aerosol-generating procedures (AGPs) poses significant risks for healthcare professionals due to the potential for airborne transmission of infectious agents, particularly in the context of respiratory pathogens like SARS-CoV-2, influenza, and Mycobacterium tuberculosis. This review synthesizes the epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, management principles, recent advances, and guideline recommendations pertaining to the screening and mitigation of AGP exposure risk. Emphasis is placed on evidence-based screening protocols, personal protective equipment (PPE), and institutional strategies for safeguarding healthcare workers, supported by recent literature and current global guidelines.

Introduction

Aerosol-generating procedures (AGPs) are defined as medical interventions that can produce airborne particles (aerosols) small enough to remain suspended in the air and potentially transmit infectious pathogens. Common AGPs include tracheal intubation, non-invasive ventilation, tracheostomy, cardiopulmonary resuscitation, and bronchoscopy. The risk of nosocomial transmission during such procedures has become a critical focus, particularly during respiratory pandemics such as COVID-19. Effective screening and risk stratification are essential for minimizing occupational exposure and protecting healthcare personnel.

Epidemiology / Disease Burden

Globally, healthcare-associated infections (HAIs) arising from AGPs represent a substantial occupational hazard. During the COVID-19 pandemic, frontline workers involved in AGPs experienced a disproportionately higher rate of infection, with meta-analyses estimating the incidence of SARS-CoV-2 infection among exposed healthcare workers to be up to 21%, compared to a 9% risk in non-exposed roles. Tuberculosis and seasonal influenza epidemics further underscore the significance of AGPs in propagating airborne infections within healthcare settings. The cumulative burden necessitates robust screening and preventive strategies to curtail transmission chains.

Pathophysiology

The generation of aerosols during certain medical procedures occurs via mechanical disruption of the respiratory tract, leading to the release of droplets and droplet nuclei containing viable pathogens. These aerosols, typically less than 5 μm in diameter, remain airborne for extended periods and can traverse distances beyond conventional droplet spread, especially in poorly ventilated environments. Pathogen viability within aerosols depends on environmental factors such as humidity, temperature, and airflow, influencing transmission dynamics. Understanding these mechanisms underlies effective screening and mitigation strategies.

Risk Factors

Several factors increase the likelihood of exposure during AGPs. These include the type and duration of the procedure, proximity to the patient, inadequate PPE use, poor ventilation, underlying host vulnerability, and the infectious status of the patient. Procedures like intubation and open suctioning are among the highest risk. Institutional factors, such as insufficient training or lack of clear protocols, further elevate exposure risk. Staff working in intensive care, emergency, and respiratory units are especially vulnerable due to frequent involvement in AGPs.

Clinical Features

While AGPs themselves are interventions rather than pathologies, the clinical implications relate to the subsequent acquisition and manifestation of airborne infections. Healthcare workers exposed to AGPs may develop symptoms consistent with the transmitted pathogen, ranging from mild upper respiratory tract symptoms to severe pneumonia, depending on the causative agent. Asymptomatic carriage and subclinical infections are also possible, underscoring the importance of routine screening and surveillance.

Diagnosis

Screening for AGP exposure risk involves a combination of procedural audit, staff exposure tracking, and pathogen surveillance. Real-time monitoring systems, coupled with occupational health reporting, enable rapid identification of at-risk personnel. Post-exposure diagnostic testing, such as PCR for respiratory viruses or interferon-gamma release assays for tuberculosis, allows early detection of infection. Environmental sampling and airflow assessments are adjunctive tools for evaluating procedural risk within clinical areas.

Treatment & Management

Management following AGP exposure centers on immediate risk assessment, implementation of post-exposure prophylaxis (if applicable), and rigorous symptom monitoring. Quarantine measures and work restrictions may be indicated based on exposure severity and the infectious agent involved. Psychological support for affected staff is critical, given the stress and anxiety associated with occupational exposure. The cornerstone of risk management remains prevention, through effective screening, PPE use, and adherence to infection control protocols.

Recent Advances / Emerging Therapies

Advances in technology and infection prevention have yielded novel approaches to minimize AGP-related risk. High-efficiency particulate air (HEPA) filtration, portable negative pressure units, and ultraviolet-C (UV-C) environmental disinfection are increasingly integrated into procedural areas. Enhanced PPE, including powered air-purifying respirators (PAPRs), offers superior protection during high-risk procedures. Digital contact tracing and real-time exposure analytics are emerging tools for rapid risk stratification and intervention.

Guideline Recommendations

Major health authorities, including the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and various specialty societies, advocate for comprehensive screening protocols encompassing pre-procedural risk assessment, procedural modifications to minimize aerosolization, and strict adherence to PPE guidelines. Routine education, simulation training, and regular audits are emphasized to ensure consistent practice. Recommendations also highlight the importance of engineering controls, such as optimized ventilation and spatial separation, alongside administrative interventions.

Conclusion

Screening for exposure risk during aerosol-generating procedures is a critical component of occupational health in the clinical environment. Recent evidence underscores the necessity of multilayered strategies encompassing procedural audit, advanced PPE, environmental controls, and continuous staff education. Adherence to updated guidelines and the integration of emerging technologies are pivotal for sustaining healthcare workforce safety amid evolving infectious threats. Ongoing research and real-world surveillance will continue to inform best practices and optimize protective measures for healthcare professionals worldwide.